Refuge Treatment Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 101 W. Broadway, Mannsville, OK 73447 Phone: 580-272-8012 |
News Archive
ImmuPharma PLC the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZORâ„¢ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzorâ„¢ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.
NPR reports on the high cost of medical school, focusing on one student, Sarah Rosen. The interest rate on her school loans "shot up to eight and a half percent, almost twice the rate [her parents] are paying after refinancing their mortgage."
A team of researchers with the Fralin Life Science Institute at Virginia Tech, working with a large international consortium, has sequenced the Y chromosome-the genetic driver of sex-determination and male fertility- in a family of malaria spreading mosquitoes.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
› Verified 8 days ago